BRPI0916532A2 - nitratos de isosorbida tendo atividade vasodilatadora - Google Patents

nitratos de isosorbida tendo atividade vasodilatadora

Info

Publication number
BRPI0916532A2
BRPI0916532A2 BRPI0916532A BRPI0916532A BRPI0916532A2 BR PI0916532 A2 BRPI0916532 A2 BR PI0916532A2 BR PI0916532 A BRPI0916532 A BR PI0916532A BR PI0916532 A BRPI0916532 A BR PI0916532A BR PI0916532 A2 BRPI0916532 A2 BR PI0916532A2
Authority
BR
Brazil
Prior art keywords
vasodilatory activity
isosorbide nitrates
isosorbide
nitrates
vasodilatory
Prior art date
Application number
BRPI0916532A
Other languages
English (en)
Inventor
Francisco Pubill Coy
José Repollés Moliner
Juan Carlos Del Castillo Nieto
Lydia Cabeza Llorente
Marisabel Mourelle Mancini
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of BRPI0916532A2 publication Critical patent/BRPI0916532A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0916532A 2008-07-22 2009-07-21 nitratos de isosorbida tendo atividade vasodilatadora BRPI0916532A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08380221A EP2149576A1 (en) 2008-07-22 2008-07-22 Isosorbide Nitrates having vasodilating activity
US12/334,986 US8211939B2 (en) 2008-07-22 2008-12-15 Isosorbide nitrates
PCT/EP2009/059387 WO2010010101A1 (en) 2008-07-22 2009-07-21 Isosorbide nitrates having vasodilating activity

Publications (1)

Publication Number Publication Date
BRPI0916532A2 true BRPI0916532A2 (pt) 2015-11-10

Family

ID=39800661

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916532A BRPI0916532A2 (pt) 2008-07-22 2009-07-21 nitratos de isosorbida tendo atividade vasodilatadora

Country Status (15)

Country Link
US (2) US8211939B2 (pt)
EP (2) EP2149576A1 (pt)
JP (1) JP2011528691A (pt)
KR (1) KR20110039562A (pt)
CN (1) CN102124010B (pt)
AR (1) AR072591A1 (pt)
AT (1) ATE507230T1 (pt)
AU (1) AU2009273233B2 (pt)
BR (1) BRPI0916532A2 (pt)
CA (1) CA2731574A1 (pt)
DE (1) DE602008006545D1 (pt)
ES (2) ES2365688T3 (pt)
MX (1) MX2011000808A (pt)
UY (1) UY32001A (pt)
WO (1) WO2010010101A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149576A1 (en) * 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
RU2015139514A (ru) * 2013-03-05 2017-04-07 Арчер Дэниелс Мидлэнд Компани Монотрифлаты изогексида и способ их синтеза
US10691097B2 (en) 2014-05-09 2020-06-23 The Boeing Company Path repeatable machining for full sized determinant assembly
US10913748B2 (en) * 2018-11-04 2021-02-09 Coeurative, Inc. Compounds useful for treating cardiovascular diseases
US10501471B1 (en) * 2018-11-04 2019-12-10 John F. Schmedtje, Jr. Compounds useful for treating cardiovascular diseases
CN113683623B (zh) * 2021-09-09 2022-08-12 中国人民解放军空军军医大学 一种no供体化合物及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3028289C2 (de) * 1980-07-25 1986-11-27 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe 2-O- und 5-O-substituierte 1.4;3.6-Dianhydro-hexit-mononitrate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
JP2628756B2 (ja) 1988-09-15 1997-07-09 シュバルツファルマ アクチェンゲゼルシャフト 新規有機ニトレート及びそれらの製造方法
US4891373A (en) 1988-11-23 1990-01-02 Pfizer Inc. Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
NL9001955A (nl) 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
FR2680173A1 (fr) 1991-08-07 1993-02-12 Hoechst Lab Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
WO1994003421A2 (en) 1992-07-30 1994-02-17 Cal International Limited Esters and combinations of an organic nitrate and a salicylate
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP1941876A1 (en) * 2006-12-28 2008-07-09 Lacer, S.A. Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
EP2149576A1 (en) * 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity

Also Published As

Publication number Publication date
MX2011000808A (es) 2011-05-30
AR072591A1 (es) 2010-09-08
ES2365688T3 (es) 2011-10-10
US8211939B2 (en) 2012-07-03
DE602008006545D1 (de) 2011-06-09
ATE507230T1 (de) 2011-05-15
CA2731574A1 (en) 2010-01-28
AU2009273233A1 (en) 2010-01-28
JP2011528691A (ja) 2011-11-24
WO2010010101A8 (en) 2011-03-10
CN102124010B (zh) 2013-12-18
EP2324033B1 (en) 2012-08-22
EP2149576A1 (en) 2010-02-03
WO2010010101A1 (en) 2010-01-28
US20100022638A1 (en) 2010-01-28
CN102124010A (zh) 2011-07-13
US20120189616A1 (en) 2012-07-26
ES2341075B1 (es) 2011-03-01
ES2341075A1 (es) 2010-06-14
KR20110039562A (ko) 2011-04-19
UY32001A (es) 2010-02-26
EP2324033A1 (en) 2011-05-25
AU2009273233B2 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
BRPI0508788A (pt) tiadiazolidinonas como inibidores de sqg - 3
BRPI0912431A2 (pt) Combinações de substâncias ativas sinergísticas
BRPI0812753A2 (pt) Combinações de substância ativas acaricidas
BRPI0716477A2 (pt) Derivados heteroarila como inibidores de quinase protéica
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
CR10701A (es) Compuestos de biaril eter urea
ECSP12012034A (es) Antagonistas de pcsk9
BRPI0915064A2 (pt) derivados de qunoxalinadiona
EP2220838A4 (en) SOFTWARE-DEFINED RADIO ARCHITECTURE
BRPI0817313A2 (pt) Derivados do ácido tetrâmico e tetrônico halogenoalcóxispirocíclicos
BRPI0718875A2 (pt) Cobertura com níveis reduzidos de ácido graxo saturado
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0914544A2 (pt) derivados de pirimidona substituídos
BRPI0817935A2 (pt) Derivados de biarila
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI1011066A2 (pt) "pirazolopirimidinas e heterociclos relacionados como inibidores de quinase
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
BRPI0922464A2 (pt) Combinações de compostos ativos
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0914301A2 (pt) derivados de pirimidin-4-ona substituída
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2370 DE 07-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.